Cite
MLA Citation
Patrick Wen et al.. “ACTR-64. PHASE 2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND CLINICAL ACTIVITY OF PI3K/mTOR INHIBITOR GDC-0084 IN GBM PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANSFERASE (MGMT) PROMOTER STATUS.” Neuro-oncology, vol. 21, n.d., p. vi28. http://access.bl.uk/ark:/81055/vdc_100101668443.0x00004c